Gefitinib Sandoz

Gefitinib Sandoz is an oral medication used to treat certain types of cancer. It works by targeting specific proteins in cancer cells to inhibit their growth. This medication is manufactured by Sandoz N.V. and is available for oral use.

Gefitinib Sandoz is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has spread or cannot be removed by surgery. It is designed to target and inhibit the epidermal growth factor receptor (EGFR), which plays a role in cancer cell growth. This medication is often prescribed for patients with specific mutations in the EGFR gene. Gefitinib Sandoz may be used as a first-line treatment or in cases where other treatments have not been effective.

Common effects of Gefitinib Sandoz may include skin rash, diarrhea, and nausea. Some users may experience fatigue, loss of appetite, or dry skin. These effects can vary in severity and may not affect everyone who takes the medication. It is important to monitor for any unusual or persistent symptoms and consult a healthcare provider if necessary.

Gefitinib Sandoz should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare provider. This medication may cause dizziness or drowsiness, so it is advisable to avoid activities that require alertness until you know how it affects you. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Gefitinib Sandoz may interact with certain medications, including those that are metabolized by the liver enzymes CYP3A4. This can affect the effectiveness of Gefitinib Sandoz or other medications. It is important to avoid grapefruit and grapefruit juice, as they can also interact with this medication. Always consult a healthcare provider before starting or stopping any medication while taking Gefitinib Sandoz.